Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan T Chlebowski

Showing results (31-40 of 366) with videos related to

Pageof 37
Sort By:
Breast Disease|December 7, 2011
Bisphosphonates and breast cancer incidence and recurrenceRowan T Chlebowski, Nananda Col
Lancet (London, England)|February 14, 2004
Menopausal hormone therapy after breast cancerRowan T Chlebowski, Nananda Col
Oncology (Williston Park, N.Y.)|February 5, 2010
Early breast and prostate cancer and clinical outcomes (fracture)Rowan T Chlebowski, Tomoko Tagawa
The New England Journal of Medicine|November 14, 2008
Tibolone in older postmenopausal womenRowan T Chlebowski, Ross Prentice
The New England Journal of Medicine|October 2, 2014
Exemestane with ovarian suppression in premenopausal breast cancerRowan T Chlebowski, Kathy Pan
The Breast Journal|June 12, 2012
Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitorsRowan T Chlebowski, Nananda Col
Journal of the National Cancer Institute|January 2, 2003
Biological significance of interventions that change breast densityRowan T Chlebowski, Anne McTiernan
Clinical Breast Cancer|September 3, 2005
Abnormal mammographic findings with short-interval follow-up recommendationRowan T Chlebowski, Iraj Khalkhali
Clinical Breast Cancer|February 8, 2014
Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancerKathy Pan, Rowan T Chlebowski
The Lancet. Oncology|November 22, 2017
Complexity of intermittent letrozole adjuvant therapyRowan T Chlebowski, Kathy Pan
Pageof 37

Showing results (31-40 of 366) with videos related to

Sort By:
Pageof 37
Breast Disease|December 7, 2011
Bisphosphonates and breast cancer incidence and recurrenceRowan T Chlebowski, Nananda Col
Lancet (London, England)|February 14, 2004
Menopausal hormone therapy after breast cancerRowan T Chlebowski, Nananda Col
Oncology (Williston Park, N.Y.)|February 5, 2010
Early breast and prostate cancer and clinical outcomes (fracture)Rowan T Chlebowski, Tomoko Tagawa
The New England Journal of Medicine|November 14, 2008
Tibolone in older postmenopausal womenRowan T Chlebowski, Ross Prentice
The New England Journal of Medicine|October 2, 2014
Exemestane with ovarian suppression in premenopausal breast cancerRowan T Chlebowski, Kathy Pan
The Breast Journal|June 12, 2012
Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitorsRowan T Chlebowski, Nananda Col
Journal of the National Cancer Institute|January 2, 2003
Biological significance of interventions that change breast densityRowan T Chlebowski, Anne McTiernan
Clinical Breast Cancer|September 3, 2005
Abnormal mammographic findings with short-interval follow-up recommendationRowan T Chlebowski, Iraj Khalkhali
Clinical Breast Cancer|February 8, 2014
Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancerKathy Pan, Rowan T Chlebowski
The Lancet. Oncology|November 22, 2017
Complexity of intermittent letrozole adjuvant therapyRowan T Chlebowski, Kathy Pan
Pageof 37